Knight Therapeutics Dividends

GUD Stock  CAD 5.29  0.01  0.19%   
As of the 22nd of November 2024, Dividends Paid is likely to drop to about 198.2 M. In addition to that, Dividend Yield is likely to drop to 0.50. Knight Therapeutics' past performance could be the main factor of why investors trade Knight Therapeutics stock today. Investors should clearly understand every aspect of the Knight Therapeutics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Knight Therapeutics' dividend schedule and payout information. Knight Therapeutics dividends can also provide a clue to the current valuation of Knight Therapeutics.
Last ReportedProjected for Next Year
Dividends Paid223 M198.2 M
Dividend Yield 0.56  0.50 
Dividend Payout Ratio 1.77  1.58 
Dividend Paid And Capex Coverage Ratio 2.86  2.72 
One of the primary advantages of investing in dividend-paying companies such as Knight Therapeutics is that dividends usually grow steadily over time. As a result, well-established companies that pay dividends typically increase their dividend payouts yearly, which many long-term traders find attractive.
  
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Knight Therapeutics must own a stock before its ex-dividend date to receive its next dividend.

Please note, there is a significant difference between Knight Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Knight Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Knight Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Compare Dividends Across Peers

Specify up to 10 symbols: